X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/14/2796336/34323/en/Roche-Completes-Acquisition-of-Telavant-from-Roivant-Including-Rights-to-Novel-TL1A-Directed-Antibody-RVT-3101-for-the-Treatment-of-Inflammatory-Bowel-Disease.html